{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:11:04Z","timestamp":1778904664573,"version":"3.51.4"},"reference-count":14,"publisher":"Japanese Society of Internal Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,5,15]]},"DOI":"10.2169\/internalmedicine.6196-25","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T22:08:33Z","timestamp":1759356513000},"page":"1397-1401","source":"Crossref","is-referenced-by-count":1,"title":["Ampicillin-dependent IgG Antibody Mediated Thrombocytopenia Confirmed Using Flow Cytometry"],"prefix":"10.2169","volume":"65","author":[{"given":"Ayane","family":"Ikeda","sequence":"first","affiliation":[{"name":"Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Konishi","sequence":"additional","affiliation":[{"name":"Division of Blood Transfusion and Cell Therapy, Ehime University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Maruta","sequence":"additional","affiliation":[{"name":"Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuhiko","family":"Kutsuna","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Ehime University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Yamanouchi","sequence":"additional","affiliation":[{"name":"Division of Blood Transfusion and Cell Therapy, Ehime University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Takao","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Ehime University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuto","family":"Takenaka","sequence":"additional","affiliation":[{"name":"Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Aster RH, Bougie DW. Drug-induced immune thrombocytopenia. N Engl J Med 357: 580-587, 2007.","DOI":"10.1056\/NEJMra066469"},{"key":"2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.21307\/immunohematology-2019-099","volume":"30","author":"BR Curtis","year":"2014","unstructured":"2. Curtis BR. Drug-induced immune thrombocytopenia: incidence, clinical features, laboratory testing, and pathogenic mechanisms. Immunohematology 30: 55-65, 2014.","journal-title":"Immunohematology","ISSN":"https:\/\/id.crossref.org\/issn\/0894-203X","issn-type":"print"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Visentin GP, Liu CY. Drug-induced thrombocytopenia. Hematol Oncol Clin North Am 21: 685-vi, 2007.","DOI":"10.1016\/j.hoc.2007.06.005"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Bakchoul T, Marini I. Drug-associated thrombocytopenia. Hematology Am Soc Hematol Educ Program 2018: 576-583, 2018.","DOI":"10.1182\/asheducation-2018.1.576"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Yamanouchi J, Hato T, Shiraishi S, Takeuchi K, Yakushijin Y, Yasukawa M. Vancomycin-induced immune thrombocytopenia proven by the detection of vancomycin-dependent anti-platelet antibody with flow cytometry. Intern Med 55: 3035-3038, 2016.","DOI":"10.2169\/internalmedicine.55.6902"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Arnold DM, Kukaswadia S, Nazi I, et al. A systematic evaluation of laboratory testing for drug-induced immune thrombocytopenia. J Thromb Haemost 11: 169-176, 2013.","DOI":"10.1111\/jth.12052"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Izakovicova P, Borens O, Trampuz A. Periprosthetic joint infection: current concepts and outlook. EFORT Open Rev 4: 482-494, 2019.","DOI":"10.1302\/2058-5241.4.180092"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Whiteside LA, Peppers M, Nayfeh TA, Roy ME. Methicillin-resistant Staphylococcus aureus in TKA treated with revision and direct intra-articular antibiotic infusion. Clin Orthop Relat Res 469: 26-33, 2011.","DOI":"10.1007\/s11999-010-1313-9"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Von Drygalski A, Curtis BR, Bougie DW, et al. Vancomycin-induced immune thrombocytopenia. N Engl J Med 356: 904-910, 2007.","DOI":"10.1056\/NEJMoa065066"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Arnold DM, Nazi I, Warkentin TE, et al. Approach to the diagnosis and management of drug-induced immune thrombocytopenia. Transfus Med Rev 27: 137-145, 2013.","DOI":"10.1016\/j.tmrv.2013.05.005"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. George JN, Raskob GE, Shah SR, et al. Drug-induced thrombocytopenia: a systematic review of published case reports. Ann Intern Med 129: 886-890, 1998.","DOI":"10.7326\/0003-4819-129-11_Part_1-199812010-00009"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Edelstein AI, Okroj KT, Rogers T, Della Valle CJ, Sporer SM. Systemic absorption of antibiotics from antibiotic-loaded cement spacers for the treatment of periprosthetic joint infection. J Arthroplasty 33: 835-839, 2018.","DOI":"10.1016\/j.arth.2017.09.043"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Slaught M, Rasmussen M, Bougie D, Aster R. Immune thrombocytopenia induced by beta-lactam antibiotics: cross-reactions of responsible antibodies with other beta-lactam drugs. Transfusion 61: 1600-1608, 2021.","DOI":"10.1111\/trf.16295"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Newland A, Godeau B, Priego V, et al. Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 study. Br J Haematol 172: 262-273, 2016.","DOI":"10.1111\/bjh.13827"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/10\/65_6196-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:26:20Z","timestamp":1778901980000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/10\/65_6196-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":14,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6196-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"article-number":"6196-25"}}